Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
British Journal of Cancer|September 20, 2000
Identification of genes differentially expressed in association with acquired cisplatin resistanceA Johnsson, I Zeelenberg, Y Min, et al.
Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1993
Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compoundsN P Vermeulen, G S Baldew, G Los, et al.
Psycho-Oncology|August 29, 2000
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trialC M Moinpour, J Sawyers Triplett, B McKnight, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytesG Los, R A De Weger, D T Van den Berg, et al.
British Journal of Cancer|December 1, 1994
Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivoD P Gately, J A Jones, R Christen, et al.
Pageof 23